DBV Technologies
DBVT
78 hedge funds and large institutions have $346M invested in DBV Technologies in 2026 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 17 increasing their positions, 24 reducing their positions, and 10 closing their positions.
70% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 10
10% more funds holding
Funds holding: 71 → 78 (+7)
1.68% less ownership
Funds ownership: 38.04% → 36.36% (-1.7%)
20% less capital invested
Capital invested by funds: $434M → $346M (-$87.9M)
29% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 24
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$23.3M |
| 2 |
LGM
Logos Global Management
San Francisco,
California
|
+$17.3M |
| 3 |
Morgan Stanley
New York
|
+$15.3M |
| 4 |
PA
Perceptive Advisors
New York
|
+$13M |
| 5 |
PSC
Patient Square Capital
Menlo Park,
California
|
+$4.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MB
MPM BioImpact
Boston,
Massachusetts
|
-$29.2M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$16M |
| 3 |
VC
Vivo Capital
Palo Alto,
California
|
-$15.5M |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$9.14M |
| 5 |
ACM
Atika Capital Management
New York
|
-$5.67M |
DBVT Hedge Fund Activity: Q2 2026 in Review
78 of the 8,317 institutional investors tracked by Wall St. Rank reported a position in DBV Technologies (DBVT) for Q2 2026, worth a combined $346M — down 20% from $434M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new DBVT positions and 10 closed out — a net gain of 7 holders — while 17 added to existing stakes and 24 trimmed.
The largest buyer was UBS Group, adding an estimated $23.3M. The largest seller was MPM BioImpact, cutting an estimated $29.2M.
- 78 institutional investors held DBV Technologies (DBVT) as of Q2 2026, up from 71 in Q1 2026.
- Funds reported $346M of DBV Technologies stock for Q2 2026, down 20% quarter-over-quarter.
- 17 funds opened new DBV Technologies positions in Q2 2026 and 10 closed out, a net change of +7 holders.
- The largest DBV Technologies buyer in Q2 2026 was UBS Group, an estimated $23.3M added.
- The largest DBV Technologies seller in Q2 2026 was MPM BioImpact, an estimated $29.2M sold.
Based on aggregated 13F filings for Q2 2026.